Biopharmaceutical Fermentation Systems (BFS) Market to Grow over $15 Billion by 2025 at a CAGR of Around 6%

Description :

According to a recent report published by Global QYResearch titled “ Global Biopharmaceutical Fermentation Systems Market (Types: Fermenters, Bioprocess Analyzers, Culture & Media Preparation, Culture Media, Buffers & Inducers, Process Monitoring Devices, Others; Application: Contract Manufacturing Organizations, Biopharmaceutical Companies, Academic Research Institutes, Contract Research Organizations, Food Industry, Others)”, the global market for biopharmaceutical fermentation systems is expected to grow at a considerable rate of around 6% CAGR and reach the market value of over $15 billion by 2025. The global BFS market is driven by improved practice of fermentation-derived products in different industries worldwide due to their low cost, natural structure, and enhanced output. Besides, mount in R&D activities in various fermentation technology fields, rise in awareness about products, technological advancements, and launch of fresh products are the key aspects anticipated to propel the growth of BFS market in the near future. Recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed towards the leading share of this segment.
 
Download Sample copy of this report@ http://globalqyresearch.com/download-sample/520849
 
Asia-Pacific Anticipated to Record Exponential Growth and Produce Huge Opportunities
 
Asia-Pacific is anticipated to present considerable opportunities in the BFS market due to speedy urbanization, varying economic profiles, climbing health care investment and spending, and rising chronic lifestyle disease incidence. On the other hand, North America was the principal market for BFS during 2017 in terms of revenue. BFS market in North America is expected to witness reasonable growth through forecasting period. Existence of vital players, augment in elderly population, well-established healthcare infrastructure, and increase in healthcare spending is anticipated to boost the BFS market in the region.
 
View Detail Report With Complete Table of Content, List of Table and Figure@ http://globalqyresearch.com/global-biopharmaceutical-fermentation-systems-market-insights-forecast-to-2025
 
Sartorius Stedim Biotech and Merck KGaA to Lead BFS Market
 
The global BFS market is extremely fragmented, with major five manufacturers accounting for leading share. Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, GE Healthcare, and Danaher Corporation are the five principal manufacturers operating in the market. Sartorius Stedim Biotech and Merck KGaA are expected to maintain considerable market share during the forecast phase. The companies have strong presence in the fermenters sector. Merck KGaA is estimated to witness huge growth in Asia-Pacific through forecasting period, owing to larger investments made by the company in developing infrastructure and advancement of new products.
 
Key Players
 
Key players included in this report are Merck KGaA, GE Healthcare, Sartorius Stedim Biotech, Nova Biomedicals, Thermo Fisher Scientific, Danaher Corporation, Eppendorf, Dickinson and Company and more.
 
The report is readily available and can be dispatched within 4hr after payment confirmation.
 
Buy this premium research report - http://globalqyresearch.com/checkout-form/0/520849
 
Would like to place an order or any question, please feel free to contact at sales@globalqyresearch.com | +44 20 3286 1546
 

Copyright © 2018 Global QYResearch